102 related articles for article (PubMed ID: 19999202)
1. Ki-67 proliferating index and histological grade, type and stage of colorectal carcinoma.
Nabi U; Nagi AH; Sami W
J Ayub Med Coll Abbottabad; 2008; 20(4):44-8. PubMed ID: 19999202
[TBL] [Abstract][Full Text] [Related]
2. Correlations of proliferation markers, p53 expression and histological findings in colorectal carcinoma.
Georgescu CV; Săftoiu A; Georgescu CC; Ciurea R; Ciurea T
J Gastrointestin Liver Dis; 2007 Jun; 16(2):133-9. PubMed ID: 17592558
[TBL] [Abstract][Full Text] [Related]
3. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
Martín R; Nieto S; Santamaría L
Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
[TBL] [Abstract][Full Text] [Related]
5. Morphological evaluation of colorectal carcinoma with grading staging and histological types.
Nabi U; Nagi AH; Riaz S; Sami W
J Pak Med Assoc; 2010 Dec; 60(12):998-1001. PubMed ID: 21381550
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis.
Kuniyasu H; Oue N; Shigeishi H; Ito R; Kato Y; Yokozaki H; Yasui W
J Exp Clin Cancer Res; 2001 Dec; 20(4):543-8. PubMed ID: 11876549
[TBL] [Abstract][Full Text] [Related]
7. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
8. Proliferative, infiltrative, and metastatic activities in colorectal tumors assessed by MIB-1 antibody.
Ishida H; Sadahiro S; Suzuki T; Ishikawa K; Kamijo A; Tajima T; Makuuchi H; Murayama C
Oncol Rep; 2003; 10(6):1741-5. PubMed ID: 14534689
[TBL] [Abstract][Full Text] [Related]
9. Thymidine labeling index in colorectal carcinoma: relation to clinicopathological parameters and to mitotic index.
Matturri L; Biondo B; Lavezzi AM
Cancer Detect Prev; 1997; 21(5):471-5. PubMed ID: 9307850
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tumor necrosis factor receptor in colorectal adenocarcinoma.
Yoshimura H; Dhar DK; Nakamoto T; Kotoh T; Takano M; Soma G; Nagasue N
Anticancer Res; 2003; 23(1A):85-9. PubMed ID: 12680198
[TBL] [Abstract][Full Text] [Related]
11. Ki-67 as a prognostic marker in colorectal cancer but not in gastric cancer.
Oshima CT; Iriya K; Forones NM
Neoplasma; 2005; 52(5):420-4. PubMed ID: 16151588
[TBL] [Abstract][Full Text] [Related]
12. High apoptotic activity and low epithelial cell proliferation with underexpression of p21(WAF1/CIP1) and p27Kip1 of mucinous carcinomas of the colorectum: comparison with well-differentiated type.
Akino F; Mitomi H; Nakamura T; Ohtani Y; Ichinoe M; Okayasu I
Am J Clin Pathol; 2002 Jun; 117(6):908-15. PubMed ID: 12047142
[TBL] [Abstract][Full Text] [Related]
13. A new cell proliferating marker: cytosolic thymidine kinase as compared to proliferating cell nuclear antigen in patients with colorectal carcinoma.
Wu J; Mao Y; He L; Wang N; Wu C; He Q; Skog S
Anticancer Res; 2000; 20(6C):4815-20. PubMed ID: 11205225
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors.
Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ
Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208
[TBL] [Abstract][Full Text] [Related]
15. Venous invasion and down-regulation of p21(WAF1/CIP1) are associated with metastasis in colorectal carcinomas.
Mitomi H; Mori A; Kanazawa H; Nishiyama Y; Ihara A; Otani Y; Sada M; Kobayashi K; Igarashi M
Hepatogastroenterology; 2005; 52(65):1421-6. PubMed ID: 16201087
[TBL] [Abstract][Full Text] [Related]
16. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
[TBL] [Abstract][Full Text] [Related]
17. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
19. [Cellular apoptosis, proliferation and bcl-2 Bax expression in colorectal carcinoma and their association with tumor prognosis].
Li L; Yan L; Liu Z; Wang Z; Wen T; Chen X; Huang G
Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):614-6, 120. PubMed ID: 11825479
[TBL] [Abstract][Full Text] [Related]
20. Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Czyzewska J
Anticancer Res; 2009 Aug; 29(8):3049-52. PubMed ID: 19661314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
